Dermapharm expands COVID-19 vaccine production capacity at ex-Merck site
The company's additional production capacities are scheduled to go into operation in May 2021
CDMO Dermapharm, a manufacturer of the Pfizer/BioNTech COVID-19 vaccine Comirnaty (formerly known as BNT162b2), says it is expanding capacity at its Reinbek, Germany site due to high demand for the shot.
Additional production capacities are now being established at Allergopharma GmbH & Co. KG, a subsidiary of Dermapharm, at Reinbek, which was formerly Merck KGaA's European allergy business before the pharma firm divested it in March 2020.
Dermapharm has said it is already begun to recruit personnel and train employees at its main production site in Brehna near Leipzig in readiness to start vaccine production as soon as possible.The additional production capacities are scheduled to go into operation in May 2021.
According to Dr Hans-Georg Feldmeier, Chairman of the Management Board of Dermapharm Holding SE, the capacities in Reinbek will "significantly exceed" its production capacities in Brehna.
Dermapharm signed a cooperation and supply agreement with BioNTech SE last September, and expanded production and special storage capacities for the formulation, as well as the aseptic filling, packaging (fill & finish) and storage of the vaccine at its mibe GmbH Arzneimittelsite site in Brehna, Germany.
The vaccine has been produced in Brehna since the beginning of October 2020.
Dermapharm said it expects the BioNTech partnership to contribute a "high double-digit million € amount" to its consolidated sales in the full year 2021.
Related News
-
News mRNA therapy for ovarian cancer and muscle wasting
Researchers demonstrate results of a promising mRNA therapy for ovarian cancer and muscle wasting caused by cachexia, a condition associated with various types of cancers and chronic diseases. -
News Pfizer CentreOne Content Refinement Q3 media buy
For 40 years Pfizer CentreOne has been guiding drug projects to success. Here’s how our services make us an altogether different kind of CDMO: -
.png)
News Bora Pharmaceuticals expands development and manufacturing capacity with landmark acquisition
Taiwan-based CDMO Bora Pharmaceuticals have acquired niche generic drugs developer TWi Pharmaceuticals, expanding their outsourced development and manufacturing services with two additional manufacturing facilities. -
.png)
News Lonza and Touchlight collaboration to bring expanded end-to-end mRNA offerings
Through a collaboration with biotech company Touchlight, Lonza is set to expand their end-to-end offering for mRNA manufacturing with additional DNA raw material sources, including Touchlight’s doggybone DNA. -
.png)
News Oxford University presents promising phase II data for malaria vaccine
The malaria vaccine R21/Matrix-M, developed by researchers at Oxford University, has produced encouraging new data for the global effort against the mosquito-borne disease. -
News NextPharma to acquire Norway manufacturing site from Takeda
Biopharmaceutical company Takeda and CDMO NextPharma have announced an acquisition agreement in which Takeda will divest from their Asker, Norway manufacturing site, set to be acquired by NextPharma. -
.png)
News Gut instinct: molecular link between COVID-19 and serotonin cells in the gut
New research may provide further evidence of the gut’s role in SARS-CoV-2 infection and disease severity with a molecular link between serotonin-producing cells in the gut and COVID-19 disease severity. -
.png)
News Novavax COVID-19 vaccine receives backing from European Medicines Agency
The European Medicines Agency has backed the Nuvaxovid COVID-19 vaccine for adults as a booster shot to other COVID-19 vaccines.
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance